D-0269-2023 Class II Terminated
FDA drug recall D-0269-2023 was initiated by Amerisource Health Services LLC on January 11, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories. The recall status is terminated (terminated May 12, 2024). Affected quantity: (a) 6670 100-count (b) 2666 500-count bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- February 22, 2023
- Initiation Date
- January 11, 2023
- Termination Date
- May 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- (a) 6670 100-count (b) 2666 500-count bottles
Product Description
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories
Reason for Recall
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Distribution Pattern
Nationwide USA
Code Information
Lots: (a) 21143211, EXP 03/31/2023; (b) 21143185, 21143193, EXP 02/28/2023